» Articles » PMID: 11380073

The Effects of Brain-derived Neurotrophic Factor on Insulin Signal Transduction in the Liver of Diabetic Mice

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2001 May 31
PMID 11380073
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Aim/hypothesis: We previously reported that repeated subcutaneous or intracerebroventricular injection of brain-derived neurotrophic factor (BDNF) reduces blood glucose concentrations in obese diabetic C57BL/KsJ-db/db mice. In this study, we assessed the effects of BDNF on insulin action in peripheral tissues of diabetic mice.

Methods: First, brain-derived neurotrophic factor (20 mg/kg) was subcutaneously given to male db/db mice for 14 days and then the insulin-stimulated tyrosine phosphorylation of insulin receptors and insulin-stimulated phosphatidylinositol (PI) 3-kinase activity in peripheral tissues was assessed. Second, we examined the effects of a single subcutaneous or intracerebroventricular brain-derived neurotrophic factor injection on insulin responsiveness in liver and skeletal muscle of streptozotocin (STZ)-induced diabetic mice. Third, the effects of brain-derived neurothrophic factor on insulin action were also examined in cultured cells.

Results: Repeated injection of BDNF to db/db mice for 14 days enhanced insulin-stimulated tyrosine phosphorylation of insulin receptors in liver and insulin-stimulated PI 3-kinase activity in liver, skeletal muscle and interscapular brown adipose tissue. We then examined the rapid effect of BDNF on insulin signalling in vivo. A single subcutaneous or intracerebroventricular injection of BDNF rapidly increased insulin-stimulated tyrosine phosphorylation of insulin receptors and PI 3-kinase activity in liver of STZ-mice. No direct effect of brain-derived neurothrophic factor was observed on insulin signalling in primary cultured hepatocytes, L6 muscle cells or 3T3-L1 adipocytes. Brain-derived neurothrophic factor did not affect either glucose uptake or gluconeogenesis in these cells.

Conclusion/interpretation: These data indicate that brain-derived neurothrophic factor rapidly enhances insulin signal transduction in liver and shows hypoglycaemic action in diabetic mice.

Citing Articles

Serum brain-derived neurotrophic factor levels in type 2 diabetes mellitus patients and its association with cognitive impairment: A meta-analysis.

He W, Chang F, Wang T, Sun B, Chen R, Zhao L PLoS One. 2024; 19(4):e0297785.

PMID: 38648255 PMC: 11034647. DOI: 10.1371/journal.pone.0297785.


Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications.

Biswas M, Vanwong N, Sukasem C Front Pharmacol. 2024; 14:1285967.

PMID: 38375208 PMC: 10875059. DOI: 10.3389/fphar.2023.1285967.


Association of BDNF gene missense polymorphism rs6265 (Val66Met) with three quantitative traits, namely, intelligence quotient, body mass index, and blood pressure: A genetic association analysis from North India.

Fatma R, Chauhan W, Shahi M, Afzal M Front Neurol. 2023; 13:1035885.

PMID: 36742047 PMC: 9894895. DOI: 10.3389/fneur.2022.1035885.


Is Brain-Derived Neurotrophic Factor a Metabolic Hormone in Peripheral Tissues?.

Iu E, Chan C Biology (Basel). 2022; 11(7).

PMID: 36101441 PMC: 9312804. DOI: 10.3390/biology11071063.


Brain-derived neurotrophic factor (BDNF): a multifaceted marker in chronic kidney disease.

Afsar B, Afsar R Clin Exp Nephrol. 2022; 26(12):1149-1159.

PMID: 36030459 DOI: 10.1007/s10157-022-02268-z.